Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics
Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]
Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days
More than one million booster jabs have been booked in the last three days as […]
CN Bio and iiCON Announce COVID-19 Research Collaboration
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 3 trial jointly run with the […]
GSK Announces Positive Phase III Efficacy and Safety Data for Daprodustat in Patients with Anaemia Due to Chronic Kidney Disease
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive results from the Phase III ASCEND (Anaemia Studies in […]
Leader in COVID Testing Launches Compliance Solution to Help Employers Meet OSHA Mandate
Vault Health, Inc. today announced the release of its COVID Compliance Solution, a new turnkey product […]
Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics […]
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]
PDC*line Pharma Opens Last Cohort of PDC-LUNG-101 Clinical Trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more